News
NEW YORK & OTTAWA, Ontario--(BUSINESS WIRE)--Turnstone Biologics, a clinical-stage immuno-oncology company leading the next generation of oncolytic viral therapies, presented pre-clinical data ...
PHOENIX--(BUSINESS WIRE)--OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, announced the presentation of preclinical data at the Society for Immunotherapy of Cancer's (SITC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback